1. Is Clinical Documentation Improvement the Answer? MAPAM /MAHIMAJoint Meeting Thursday, November 19, 2009 Thomas D. Sills, M.D. Lori Beaudry, CCS-P Clinical Financial Resource…

Slide 1THROMBOPHILIA ANDCORONARY ARTERY DISEASE Giovanni Barillari ANCO FVG Palmanova 17 ottobre 2009 Slide 2 Slide 3 Proteina C: Meccanismo anticoagulante TM EPCR Endothelial…

1. DEEP VEIN THROMBOSISHistory Taking 2. 1) Do you have any pain or tender spots in your legs? 2) Have you noticed any new swelling in your legs? 3) Does the pain or swelling…

Deep Vein Thrombosis Deep Vein Thrombosis Hossam Bahy, MD Venous ThromboEbolism Deep Vein Thrombosis & Pulmonary Embolism Venous Thrombo-Embolism Clinical entity, lethal,…

Slide 1Warfarin toxicity Presented by: Dr.Somaia Janah Presented by: Dr.Somaia Janah Slide 2 is an anticoagulant normally used in the prevention of thrombosis, thromboembolism…

Slide 1Suresh Vedantham, M.D. Interventional Radiologist Associate Professor of Radiology & Surgery Washington University School of Medicine Vice-Chair, Venous Disease…

Slide 1 Spotlight Case New Oral Anticoagulants Slide 2 This presentation is based on the December 2013 AHRQ WebM&M Spotlight Case –See the full article at http://webmm.ahrq.govhttp://webmm.ahrq.gov…

Slide 1 Chapter Eleven Venous Disease Coalition Chronic Venous Insufficiency VTE Toolkit Slide 2 Post-Thrombotic Venous Reflux Disease VTE Toolkit Seen in 20-50% of patients…

Slide 1 Slide 2 Slide 3 Thrombophlebitis Formation of a venous clot depends on the presence of of at least of one of Virchow’s triad factors -venous stasis -injury to vessel…

Slide 1 بسم اللة الرحمن الرحيم Slide 2 Presented by Yasser Hamed MD Neurology In Children Stroke Slide 3 Pediatrics is the branch of medicine that deals…